Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells

被引:21
作者
Long, Joseph [1 ,2 ]
Hoban, Megan D. [1 ]
Cooper, Aaron R. [3 ]
Kaufman, Michael L. [1 ]
Kuo, Caroline Y. [4 ]
Campo-Fernandez, Beatriz [1 ]
Lumaquin, Dianne [1 ]
Hollis, Roger P. [1 ]
Wang, Xiaoyan [5 ]
Kohn, Donald B. [1 ,6 ]
Romero, Zulema [1 ]
机构
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, 3146 Terasaki Life Sci Bldg, Los Angeles, CA 90095 USA
[2] Calif State Univ Northridge, Biol Dept, Northridge, CA 91330 USA
[3] Univ Calif Los Angeles, Mol Biol Interdept PhD Program, Los Angeles, CA 90095 USA
[4] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pediat, Div Allergy & Immunol, Los Angeles, CA 90095 USA
[5] Univ Calif Los Angeles, Dept Internal Med & Hlth Serv Res, Los Angeles, CA 90095 USA
[6] Univ Calif Los Angeles, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90095 USA
关键词
ZINC-FINGER NUCLEASES; SEVERE COMBINED IMMUNODEFICIENCY; STEM-CELLS; RETROVIRAL VECTOR; BCL11A KNOCKDOWN; COPY NUMBER; DISEASE; THERAPY; CRISPR-CAS9; THALASSEMIA;
D O I
10.1016/j.ymthe.2017.11.001
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The use of engineered nucleases combined with a homologous DNA donor template can result in targeted gene correction of the sickle cell disease mutation in hematopoietic stem and progenitor cells. However, because of the high homology between the adjacent human beta- and delta-globin genes, off-target cleavage is observed at delta-globin when using some endonucleases targeted to the sickle mutation in beta-globin. Introduction of multiple double-stranded breaks by endonucleases has the potential to induce intergenic alterations. Using a novel droplet digital PCR assay and high-throughput sequencing, we characterized the frequency of rearrangements between the beta- and delta-globin paralogs when delivering these nucleases. Pooled CD34(+) cells and colony-forming units from sickle bone marrow were treated with nuclease only or including a donor template and then analyzed for potential gene rearrangements. It was observed that, in pooled CD34(+) cells and colony-forming units, the intergenic beta-delta-globin deletion was the most frequent rearrangement, followed by inversion of the intergenic fragment, with the inter-chromosomal translocation as the least frequent. No rearrangements were observed when endonuclease activity was restricted to on-target beta-globin cleavage. These findings demonstrate the need to develop site-specific endonucleases with high specificity to avoid unwanted gene alterations.
引用
收藏
页码:468 / 479
页数:12
相关论文
共 50 条
  • [31] Safe and Effective In Vivo Targeting and Gene Editing in Hematopoietic Stem Cells: Strategies for Accelerating Development
    Cannon, Paula
    Asokan, Aravind
    Czechowicz, Agnieszka
    Hammond, Paula
    Kohn, Donald B.
    Lieber, Andre
    Malik, Punam
    Marks, Peter
    Porteus, Matthew
    Verhoeyen, Els
    Weissman, Drew
    Weissman, Irving
    Kiem, Hans-Peter
    HUMAN GENE THERAPY, 2021, 32 (1-2) : 31 - 42
  • [32] Gene editing without ex vivo culture evades genotoxicity in human hematopoietic stem cells
    Zeng, Jing
    Nguyen, My Anh
    Liu, Pengpeng
    Silva, Lucas Ferreira da
    Levesque, Sebastien
    Lin, Linda Y.
    Justus, David G.
    Petri, Karl
    Clement, Kendell
    Porter, Shaina N.
    Verma, Archana
    Neri, Nola R.
    Rosanwo, Tolulope
    Ciuculescu, Marioara-Felicia
    Abriss, Daniela
    Mintzer, Esther
    Maitland, Stacy A.
    Demirci, Selami
    Cha, Hye Ji
    Orkin, Stuart H.
    Tisdale, John F.
    Williams, David A.
    Zhu, Lihua Julie
    Pruett-Miller, Shondra M.
    Pinello, Luca
    Joung, J. Keith
    Pattanayak, Vikram
    Manis, John P.
    Armant, Myriam
    Pellin, Danilo
    Brendel, Christian
    Wolfe, Scot A.
    Bauer, Daniel E.
    CELL STEM CELL, 2025, 32 (02) : 191 - 208.e11
  • [33] Gene Therapy Through Autologous Transplantation of Gene-Modified Hematopoietic Stem Cells
    Kohn, Donald B.
    Pai, Sung-Yun
    Sadelain, Michel
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2013, 19 (01) : S64 - S69
  • [34] Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
    DeWitt, Mark A.
    Magis, Wendy
    Bray, Nicolas L.
    Wang, Tianjiao
    Berman, Jennifer R.
    Urbinati, Fabrizia
    Heo, Seok-Jin
    Mitros, Therese
    Munoz, Denise P.
    Boffelli, Dario
    Kohn, Donald B.
    Walters, Mark C.
    Carroll, Dana
    Martin, David I. K.
    Corn, Jacob E.
    SCIENCE TRANSLATIONAL MEDICINE, 2016, 8 (360)
  • [35] Nonredundant and locus-specific gene repression functions of PRC1 paralog family members in human hematopoietic stem/progenitor cells
    van den Boom, Vincent
    Rozenveld-Geugien, Marjan
    Bonardi, Francesco
    Malanga, Donatella
    van Gosliga, Djoke
    Heijink, Anne Margriet
    Viglietto, Giuseppe
    Morrone, Giovanni
    Fusetti, Fabrizia
    Vellenga, Edo
    Schuringa, Jan Jacob
    BLOOD, 2013, 121 (13) : 2452 - 2461
  • [36] The impact of copy number variation on local gene expression in mouse hematopoietic stem and progenitor cells
    Cahan, Patrick
    Li, Yedda
    Izumi, Masayo
    Graubert, Timothy A.
    NATURE GENETICS, 2009, 41 (04) : 430 - 437
  • [37] CD34+cells from dental pulp stem cells with a ZFN-mediated and homology-driven repair-mediated locus-specific knock-in of an artificial β-globin gene
    Chattong, S.
    Ruangwattanasuk, O.
    Yindeedej, W.
    Setpakdee, A.
    Manotham, K.
    GENE THERAPY, 2017, 24 (07) : 425 - 432
  • [38] Cyclosporine H Overcomes Innate Immune Restrictions to Improve Lentiviral Transduction and Gene Editing In Human Hematopoietic Stem Cells
    Petrillo, Carolina
    Thorne, Lucy G.
    Unali, Giulia
    Schiroli, Giulia
    Giordano, Anna M. S.
    Piras, Francesco
    Cuccovillo, Ivan
    Petit, Sarah J.
    Ahsan, Fatima
    Noursadeghi, Mandad
    Clare, Simon
    Genovese, Pietro
    Gentner, Bernhard
    Naldini, Luigi
    Towers, Greg J.
    Kajaste-Rudnitski, Anna
    CELL STEM CELL, 2018, 23 (06) : 820 - +
  • [39] Development of gene editing strategies for human β-globin (HBB) gene mutations
    Kalkan, Batuhan Mert
    Kala, Ezgi Yagmur
    Yuce, Melek
    Alpaslan, Medine Karadag
    Kocabas, Fatih
    GENE, 2020, 734
  • [40] Mouse models in hematopoietic stem cell gene therapy and genome editing
    Radtke, Stefan
    Humbert, Olivier
    Kiem, Hans-Peter
    BIOCHEMICAL PHARMACOLOGY, 2020, 174